HOOK - Hookipa Pharma Inc
IEX Last Trade
5.11
-0.100 -1.957%
Share volume: 11,401
Last Updated: Fri 30 Aug 2024 09:59:50 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$5.21
-0.10
-1.92%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-11 | 2022-11-14 | 2023-03-15 | 2023-05-11 | 2023-08-10 | 2023-11-09 | 2024-03-22 | 2024-05-09 | |
| Assets | |||||||||
| Total Assets | 172.212 M | 151.526 M | 170.454 M | 163.088 M | 191.110 M | 164.010 M | 161.337 M | 145.871 M | |
| Current Assets | 149.077 M | 129.611 M | 147.196 M | 139.913 M | 168.143 M | 139.471 M | 147.116 M | 132.710 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 12.996 M | 11.302 M | 12.159 M | 11.850 M | 12.095 M | 8.745 M | 10.749 M | 9.190 M | |
| Short Term Investments | 12.996 M | 11.302 M | 12.159 M | 11.850 M | 12.095 M | 8.745 M | 10.749 M | 9.190 M | |
| Total Receivables | 17.640 M | 18.043 M | 22.012 M | 18.463 M | 20.461 M | 23.050 M | 19.271 M | 30.769 M | |
| Current Cash | 117.918 M | 99.776 M | 112.488 M | 109.600 M | 135.587 M | 107.676 M | 117.096 M | 92.751 M | |
| Total Non-current Assets | 23.135 M | 21.915 M | 23.258 M | 23.175 M | 22.967 M | 24.539 M | 14.221 M | 13.161 M | |
| Property Plant Equipment | 16.952 M | 16.516 M | 17.970 M | 17.975 M | 18.222 M | 20.167 M | 7.742 M | 7.332 M | |
| Other Assets | 5.765 M | 4.989 M | 4.869 M | 4.779 M | 4.323 M | 3.953 M | 6.054 M | 5.625 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 172.212 M | 151.526 M | 170.454 M | 163.088 M | 191.110 M | 164.010 M | 161.337 M | 145.871 M | |
| Total liabilities | 40.258 M | 38.178 M | 67.937 M | 79.609 M | 78.780 M | 68.959 M | 71.480 M | 41.349 M | |
| Total current liabilities | 27.224 M | 26.052 M | 35.632 M | 44.209 M | 46.245 M | 40.576 M | 41.988 M | 29.508 M | |
| Accounts Payable | 5.637 M | 7.824 M | 5.488 M | 7.075 M | 11.645 M | 8.929 M | 12.498 M | 11.201 M | |
| Other liabilities | 9.227 M | 8.864 M | 29.084 M | 33.428 M | 30.883 M | 27.053 M | 25.691 M | 8.487 M | |
| Current long term debt | 3.070 M | 2.951 M | 3.282 M | 3.786 M | 2.628 M | 2.524 M | 2.758 M | 2.728 M | |
| Long term debt | 3.807 M | 3.262 M | 3.221 M | 1.972 M | 1.652 M | 1.330 M | 3.801 M | 3.354 M | |
| Other liabilities | 9.227 M | 8.864 M | 29.084 M | 33.428 M | 30.883 M | 27.053 M | 25.691 M | 8.487 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 131.954 M | 113.348 M | 102.517 M | 83.479 M | 112.330 M | 95.051 M | 89.857 M | 104.522 M | |
| Common stock | 72.195 M | 72.231 M | 72.586 M | 72.218 M | 82.705 M | 110.388 M | 112.795 M | 125.388 M | |
| Retained earnings | -257.090 M | -275.370 M | -287.681 M | -307.361 M | -325.377 M | -344.443 M | -369.261 M | -354.878 M |